Novel Adjuvant S-540956 Targets Lymph Nodes and Reduces Genital Recurrences and Vaginal Shedding of HSV-2 DNA When Administered with HSV-2 Glycoprotein D as a Therapeutic Vaccine in Guinea PigsSita Awasthi, Harvey M. Friedman, John M. Lubinski et al.|Viruses|2023Cited by 3
Seroconversion Is Misleading as a Test for HSV-2 Infection in Prophylactic Genital Herpes Vaccine Trials: Results of Vaccine Studies in Guinea PigsValerie Bromberg, Harvey M. Friedman, John M. Lubinski et al.|Viruses|2025Cited by 1
Preventing neonatal herpes: Protection after maternal mRNA-lipid nanoparticle vaccination equals or exceeds that from prior maternal genital infection in murine modelsAngela Desmond, Harvey M. Friedman, Norbert Pardi et al.|The Journal of Immunology|2022Cited by 0